Comment on the National Institute for Clinical Excellence technology appraisal Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease /
Health Technology Board for Scotland.
National Institute for Clinical Excellence (Great Britain).Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease.
Glasgow : Health Technology Board for Scotland,
2001.
Cover title.
Includes bibliographical references.
Cholinesterase inhibitors
Alzheimer's disease